Thursday, May 6, 2010

Are We Seeing the New FDA Emerge?

According to a New York Times editorial--
http://www.nytimes.com/2010/05/05/opinion/05wed3.html

--there may be positive changes in the air at the FDA, consistent with the more-hard-nosed team that the Obama administration had appointed to replace the generally pro-business folks of the previous regime. According to the Times:
  • The percentage of members of advisory boards granted waivers due to conflicts of interest has been reduced from 15 to 5 since 2007
  • Commissioner Margaret Hamburg has issued a letter to staff that any future proposed waivers have to be justified by descriptions of how hard the staff worked to try to find a neutral expert first
  • FDA will now release the name of the company involved in the conflict, and a rough dollar amount of the conflict, if a waiver is granted, as part of increased disclosure

The Times continues to hope that there will be less need for disclosure and no conflicts of interest, but also agrees these are all positive steps.

2 comments:

Audrina Majella said...

I think that's good news. If the percentage of its success raise into high peak well the administration would be praise by it's subordinate's and constituents. If they used a management business consultancy assistance, i think its only fair if they'd share it to us.

Hannah said...

This is Hannah Bevills, I am an editor with Hospital.com. We are a medical publication whose focus is geared towards promoting awareness on hospitals, including information, news, and reviews on them. Given the relevance of what you are offering from your site and what our mission is, I feel we may be able to collaborate in some way or another, I look forward to your response regarding the matter. Thanks!

Hannah Bevills
hannah.bevills@gmail.com
Hospital.com